Asklepios Kliniken GmbH & Co. KGaA

Hamburg 22763

3 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer, Esophageal Adenocarcinoma, Extensive-stage Small Cell Lung Cancer (ES-SCLC), Gastroesophageal Junction Adenocarcinoma, Liposarcoma, Dedifferentiated, Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Myocardial Infarction, Small Cell Lung Cancer (SCLC), Solid Tumours

Studies at this site

• Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread — Recruiting now
• DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations — Recruiting now
• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed